Persimmon is the only hybrid telehealth model in the U.S. that plans to disrupt the medical aesthetics industry. With a proprietary technology using both an app and website, Persimmon has created the largest in-home healthcare network with an army of nurses creating ongoing barriers to entry. Funded by Draper Associates and with an exclusive deal with Allergan in place, Persimmon has hundreds of 5-star reviews for services and no early direction competition. The company is currently growing revenues by 35% each month.

Seed Healthcare has performed seed fund raising for Persimmon, as well as Board Advisory services.